Weekly roundup: June kickstarts with an abundance of appointments – Optimum Strategic CommunicationsLink to: Commit Biologics appoints leading industry experts to newly formed Scientific Advisory Boar...

Its been a busy week in the industry from Amber Implants announcing the results of its 1yr follow-up data for VCFix to appointments with iOnctura bolstering its leadership team, and Asgard Therapeutics and Commit Biologics strengthening their advisory boards #OptimumNewsletter ⬇️

Weekly roundup: Success for Optimum clients in and out of the clinic – Optimum Strategic CommunicationsLink to: Bionical Emas and Pharma Resources Announce Exclusive Global Clinical Trial Supply Partn...

It has been another great week for Optimum clients with Poolbeg being granted US FDA Orphan Drug Designation and Nucleome and STORM’s fantastic appointments. Subscribe to our weekly round-up to never miss an edition!
#OptimumNewsletter #HealthcareCommunications

Weekly roundup: A week of deals for Optimum clients despite turbulent markets – Optimum Strategic CommunicationsLink to: The must attend healthcare conference in Summer/Winter 2025Scroll to top

From Poolbeg Pharma’s successful £4.865 million fundraising, to the deepening of Novo Nordisk Foundation’s partnership with WHO, it has been a week that has shown resilience despite turbulent market conditions. Subscribe to our newsletter to ensure you never miss an edition ⬇️
#OptimumNewsletter